Back to Search Start Over

Speech markers of depression dimensions across cognitive status.

Authors :
Soleimani L
Ouyang Y
Cho S
Kia A
Beeri MS
Lin HM
Ravona-Springer R
Ramsingh N
Liberman MY
Grossman M
Nevler N
Source :
Alzheimer's & dementia (Amsterdam, Netherlands) [Alzheimers Dement (Amst)] 2024 Aug 01; Vol. 16 (3), pp. e12604. Date of Electronic Publication: 2024 Aug 01 (Print Publication: 2024).
Publication Year :
2024

Abstract

Introduction: Depression and its components significantly impact dementia prediction and severity, necessitating reliable objective measures for quantification.<br />Methods: We investigated associations between emotion-based speech measures (valence, arousal, and dominance) during picture descriptions and depression dimensions derived from the geriatric depression scale (GDS, dysphoria, withdrawal-apathy-vigor (WAV), anxiety, hopelessness, and subjective memory complaint).<br />Results: Higher WAV was associated with more negative valence (estimate = -0.133, p  = 0.030). While interactions of apolipoprotein E (APOE) 4 status with depression dimensions on emotional valence did not reach significance, there was a trend for more negative valence with higher dysphoria in those with at least one APOE4 allele (estimate = -0.404, p  = 0.0846). Associations were similar irrespective of dementia severity.<br />Discussion: Our study underscores the potential utility of speech biomarkers in characterizing depression dimensions. In future research, using emotionally charged stimuli may enhance emotional measure elicitation. The role of APOE on the interaction of speech markers and depression dimensions warrants further exploration with greater sample sizes.<br />Highlights: Participants reporting higher apathy used more negative words to describe a neutral picture.Those with higher dysphoria and at least one APOE4 allele also tended to use more negative words.Our results suggest the potential use of speech biomarkers in characterizing depression dimensions.<br />Competing Interests: The authors have no conflicts of interest to declare. Disclosures are available in the supporting information.<br /> (© 2024 The Author(s). Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring published by Wiley Periodicals LLC on behalf of Alzheimer's Association.)

Details

Language :
English
ISSN :
2352-8729
Volume :
16
Issue :
3
Database :
MEDLINE
Journal :
Alzheimer's & dementia (Amsterdam, Netherlands)
Publication Type :
Academic Journal
Accession number :
39092182
Full Text :
https://doi.org/10.1002/dad2.12604